A bispecific nanobody-drug conjugate targeting TROP2 and c-Met for low-concentration, single-dose treatment of pancreatic cancer. (linkinghub.elsevier.com)

Authors: Ning W … Luo W Journal: Cell Reports Medicine Published: 2026-04-21 DOI: https://doi.org/10.1016/j.xcrm.2026.102688